Multiple myeloma

Por Moehler, Thomas., Goldschmidt, Hartmut.
Publicado em 2011

Diagnostic and therapeutic approaches to multiple myeloma patients: ‘Real-world’ data from representative multicentre treatment surveys in Germany between 2008 and 2011

Por Moehler, Thomas M., Merz, Maximilian, Kellermann, Lenka, Goldschmidt, Hartmut, Knauf, Wolfgang
Publicado no Oncol Lett (2016)

DNA methylation score is predictive of myeloma cell sensitivity to 5-azacitidine

Por Moreaux, Jérôme, Bruyer, Angelique, Veyrune, Jean-Luc, Goldschmidt, Hartmut, Hose, Dirk, Klein, Bernard
Publicado no Br J Haematol (2014)

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

Por Viziteu, Elena, Grandmougin, Camille, Goldschmidt, Hartmut, Seckinger, Anja, Hose, Dirk, Klein, Bernard, Moreaux, Jerome
Publicado no Br J Cancer (2016)

Krüppel-like factor 4 blocks tumor cell proliferation and promotes drug resistance in multiple myeloma

Por Schoenhals, Matthieu, Kassambara, Alboukadel, Veyrune, Jean-Luc, Moreaux, Jerome, Goldschmidt, Hartmut, Hose, Dirk, Klein, Bernard
Publicado em 2013

Efficacy of single versus boost vaccination against influenza virus in patients with multiple myeloma

Por Hahn, Michael, Schnitzler, Paul, Schweiger, Brunhilde, Kunz, Christina, Ho, Anthony D., Goldschmidt, Hartmut, Schmitt, Michael
Publicado no Haematologica (2015)

Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma

Por Condomines, Maud, Hose, Dirk, Rème, Thierry, Requirand, Guilhem, Hundemer, Michael, Schoenhals, Matthieu, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2009

Osteoclast-gene expression profiling reveals osteoclast-derived CCR2 chemokines promoting myeloma cell migration

Por Moreaux, Jérôme, Hose, Dirk, Kassambara, Alboukadel, Rème, Thierry, Moine, Philippe, Requirand, Guilhem, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2011

The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications

Por Hemminki, Kari, Försti, Asta, Tuuminen, Raimo, Hemminki, Otto, Goldschmidt, Hartmut, Sundquist, Kristina, Sundquist, Jan, Li, Xinjun
Publicado no Sci Rep (2016)

IL-6 and MYC collaborate in plasma cell tumor formation in mice

Por Rutsch, Sebastian, Neppalli, Vishala T., Shin, Dong-Mi, DuBois, Wendy, Morse, Herbert C., Goldschmidt, Hartmut, Janz, Siegfried
Publicado em 2010

Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma

Por Kassambara, Alboukadel, Hose, Dirk, Moreaux, Jérôme, Rème, Thierry, Torrent, Jennifer, Rossi, Jean François, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2012

Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells

Por Kassambara, Alboukadel, Schoenhals, Matthieu, Moreaux, Jérôme, Veyrune, Jean-Luc, Rème, Thierry, Goldschmidt, Hartmut, Hose, Dirk, Klein, Bernard
Publicado em 2013

A new method for class prediction based on signed-rank algorithms applied to Affymetrix(® )microarray experiments

Por Rème, Thierry, Hose, Dirk, De Vos, John, Vassal, Aurélien, Poulain, Pierre-Olivier, Pantesco, Véronique, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2008

Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myeloma

Por Sachpekidis, Christos, Hillengass, Jens, Goldschmidt, Hartmut, Mosebach, Jennifer, Pan, Leyun, Schlemmer, Heinz-Peter, Haberkorn, Uwe, Dimitrakopoulou-Strauss, Antonia
Publicado no Am J Nucl Med Mol Imaging (2015)

Flow cytometry‐based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis

Por Lisenko, Katharina, Schönland, Stefan O., Jauch, Anna, Andrulis, Mindaugas, Röcken, Christoph, Ho, Anthony D., Goldschmidt, Hartmut, Hegenbart, Ute, Hundemer, Michael
Publicado no Cancer Med (2016)

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays

Por Mahtouk, Karène, Moreaux, Jérôme, Hose, Dirk, Rème, Thierry, Meißner, Tobias, Jourdan, Michel, Rossi, Jean François, Pals, Steven T, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2010

Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma

Por Hillengass, Jens, Ayyaz, Sofia, Kilk, Kerstin, Weber, Marc-André, Hielscher, Thomas, Shah, Rajiv, Hose, Dirk, Delorme, Stefan, Goldschmidt, Hartmut, Neben, Kai
Publicado em 2012

A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy

Por Kassambara, Alboukadel, Gourzones-Dmitriev, Claire, Sahota, Surinder, Rème, Thierry, Moreaux, Jérôme, Goldschmidt, Hartmut, Constantinou, Angelos, Pasero, Philippe, Hose, Dirk, Klein, Bernard
Publicado em 2014

FOXM1 is a therapeutic target for high-risk multiple myeloma

Por Gu, Chunyan, Yang, Ye, Sompallae, Ramakrishna, Xu, Hongwei, Tompkins, Van S., Holman, Carol, Hose, Dirk, Goldschmidt, Hartmut, Tricot, Guido, Zhan, Fenghuang, Janz, Siegfried
Publicado no Leukemia (2015)

Expression of genes encoding for proteins involved in heparan sulphate and chondroitin sulphate chain synthesis and modification in normal and malignant plasma cells

Por Bret, Caroline, Hose, Dirk, Reme, Thierry, Sprynski, Anne-Catherine, Mahtouk, Karène, Schved, Jean-François, Quittet, Philippe, Rossi, Jean-François, Goldschmidt, Hartmut, Klein, Bernard
Publicado em 2009